Anoikis mediators in oral squamous cell carcinoma

Oral Diseases

Volumn 17, Issue 4, 2011, Pages 355-361

  Bunek, J ^a   Kamarajan, P ^a   Kapila, Y L ^a  

^a UNIVERSITY OF MICHIGAN SCHOOL OF DENTISTRY   (United States)

Author keywords

Anoikis; Extracellular matrix; Fas CD95; Focal adhesion kinase; Oral squamous cell carcinoma; Receptor interacting protein

Indexed keywords

CASPASE 3; DEATH DOMAIN RECEPTOR SIGNALING ADAPTOR PROTEIN; FOCAL ADHESION KINASE; INTEGRIN RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; RECEPTOR INTERACTING PROTEIN 140; X BOX BINDING PROTEIN 1;

ANOIKIS; CANCER RESISTANCE; CELL SURVIVAL; ENZYME ACTIVATION; MOUTH CARCINOMA; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA; UPREGULATION;

ANOIKIS; ANTIGENS, CD44; ANTIGENS, CD95; CARCINOMA, SQUAMOUS CELL; CASPASE 3; DEATH DOMAIN RECEPTOR SIGNALING ADAPTOR PROTEINS; FOCAL ADHESION PROTEIN-TYROSINE KINASES; HUMANS; MOUTH NEOPLASMS; RECEPTOR-INTERACTING PROTEIN SERINE-THREONINE KINASES; SIGNAL TRANSDUCTION;

EID: 79953739003     PISSN: 1354523X     EISSN: 16010825     Source Type: Journal    
DOI: 10.1111/j.1601-0825.2010.01763.x     Document Type: Review

References (97)

1. Afify A, Purnell P, Nguyen L (2009). Role of CD44s and CD44v6 on human breast cancer cell adhesion, migration, and invasion. Exp Mol Pathol 86: 95-100.
2. Ailles L, Prince M (2009). Cancer stem cells in head and neck squamous cell carcinoma. Methods Mol Biol 568: 175-193.
3. Aronsohn MS, Brown HM, Hauptman G, Kornberg LJ (2003). Expression of focal adhesion kinase and phosphorylated focal adhesion kinase in squamous cell carcinoma of the larynx. Laryngoscope 113: 1944-1948.
4. Balsara BR, Testa JR (2002). Chromosomal imbalances in human lung cancer. Oncogene 21: 6877-6883.
5. Bellail AC, Qi L, Mulligan P, Chhabra V, Hao C (2009). TRAIL agonists on clinical trials for cancer therapy: the promises and the challenges. Rev Recent Clin Trials 4: 34-41.
6. Bockmuhl U, Petersen S, Schmidt S et al (1997). Patterns of chromosomal alterations in metastasizing and nonmetastasizing primary head and neck carcinomas. Cancer Res 57: 5213-5216.
7. Boisvert-Adamo K, Aplin AE (2006). B-RAF and PI-3 kinase signaling protect melanoma cells from anoikis. Oncogene 25: 4848-4856.
8. Bouchard V, Demers MJ, Thibodeau S et al (2007). Fak/Src signaling in human intestinal epithelial cell survival and anoikis: differentiation state-specific uncoupling with the PI3-K/Akt-1 and MEK/Erk pathways. J Cell Physiol 212: 717-728.
9. Bozzo C, Sabbatini M, Tiberio R et al (2006). Activation of caspase-8 triggers anoikis in human neuroblastoma cells. Neurosci Res 56: 145-153.
10. Chiarugi P (2008). From anchorage dependent proliferation to survival: lessons from redox signalling. IUBMB Life 60: 301-307.
11. Choi S, Kim Y, Park H et al (2009). Syndecan-2 overexpression regulates adhesion and migration through cooperation with integrin alpha2. Biochem Biophys Res Commun 384: 231-235.
12. Costelli P, Aoki P, Zingaro B et al (2003). Mice lacking TNFalpha receptors 1 and 2 are resistant to death and fulminant liver injury induced by agonistic anti-Fas antibody. Cell Death Differ 10: 997-1004.
13. Dai R, Iwama A, Wang S, Kapila YL (2005). Disease-associated fibronectin matrix fragments trigger anoikis of human primary ligament cells: p53 and c-myc are suppressed. Apoptosis 10: 503-512.
14. Decline F, Rousselle P (2001). Keratinocyte migration requires alpha2beta1 integrin-mediated interaction with the laminin 5 gamma2 chain. J Cell Sci 114: 811-823.
15. Diaz-Montero CM, Wygant JN, McIntyre BW (2006). PI3-K/Akt-mediated anoikis resistance of human osteosarcoma cells requires Src activation. Eur J Cancer 42: 1491-1500.
16. Eble JA, Haier J (2006). Integrins in cancer treatment. Curr Cancer Drug Targets 6: 89-105.
17. Engbers-Buijtenhuijs P, Kamphuis M, van der Sluijs Veer G et al (2005). A novel time resolved fluorometric assay of anoikis using Europium-labelled Annexin V in cultured adherent cells. Apoptosis 10: 429-437.
18. Frisch SM, Francis H (1994). Disruption of epithelial cell-matrix interactions induces apoptosis. J Cell Biol 124: 619-626.
19. Frisch SM, Screaton RA (2001). Anoikis mechanisms. Curr Opin Cell Biol 13: 555-562.
20. Frisch SM, Vuori K, Ruoslahti E, Chan-Hui PY (1996). Control of adhesion-dependent cell survival by focal adhesion kinase. J Cell Biol 134: 793-799.
21. Fulda S, Debatin KM (2004). Exploiting death receptor signaling pathways for tumor therapy. Biochim Biophys Acta 1705: 27-41.
22. Garrison JB, Kyprianou N (2004). Novel targeting of apoptosis pathways for prostate cancer therapy. Curr Cancer Drug Targets 4: 85-95.
23. Giannelli G, Milillo L, Marinosci F et al (2001). Altered expression of integrins and basement membrane proteins in malignant and pre-malignant lesions of oral mucosa. J Biol Regul Homeost Agents 15: 375-380.
24. Gniadecki R (1998). Regulation of keratinocyte proliferation. Gen Pharmacol 30: 619-622.
25. Gratas C, Tohma Y, Barnas C et al (1998). Up-regulation of Fas (APO-1/CD95) ligand and down-regulation of Fas expression in human esophageal cancer. Cancer Res 58: 2057-2062.
26. Green DR (2000). Apoptotic pathways: paper wraps stone blunts scissors. Cell 102: 1-4.
27. Gupta R, Sharma SC, Das SN (2008). Association of TNF-alpha and TNFR1 promoters and 3' UTR region of TNFR2 gene polymorphisms with genetic susceptibility to tobacco-related oral carcinoma in Asian Indians. Oral Oncol 44: 455-463.
28. Habib AA, Chatterjee S, Park SK et al (2001). The epidermal growth factor receptor engages receptor interacting protein and nuclear factor-kappa B (NF-kappa B)-inducing kinase to activate NF-kappa B. Identification of a novel receptor-tyrosine kinase signalosome. J Biol Chem 276: 8865-8874.
29. Haenssen KK, Caldwell SA, Shahriari KS et al (2010). ErbB2 requires integrin alpha 5 for anoikis resistance via Src regulation of receptor activity in human mammary epithelial cells. J Cell Sci 123: 1373-1382.
30. Hao JL, Cozzi PJ, Khatri A, Power CA, Li Y (2010). CD147/EMMPRIN and CD44 are potential therapeutic targets for metastatic prostate cancer. Curr Cancer Drug Targets 10: 287-306.
31. Harper LJ, Costea DE, Gammon L et al (2010). Normal and malignant epithelial cells with stem-like properties have an extended G2 cell cycle phase that is associated with apoptotic resistance. BMC Cancer 10: 166.
32. Hauptschein RS, Sloan KE, Torella C et al (2005). Functional proteomic screen identifies a modulating role for CD44 in death receptor-mediated apoptosis. Cancer Res 65: 1887-1896.
33. Ishida H, Wada K, Masuda T et al (2007). Critical role of estrogen receptor on anoikis and invasion of squamous cell carcinoma. Cancer Sci 98: 636-643.
34. Iwase M, Watanabe H, Kondo G, Ohashi M, Nagumo M (2003). Enhanced susceptibility of oral squamous cell carcinoma cell lines to FAS-mediated apoptosis by cisplatin and 5-fluorouracil. Int J Cancer 106: 619-625.
35. Janes SM, Watt FM (2004). Switch from alphavbeta5 to alphavbeta6 integrin expression protects squamous cell carcinomas from anoikis. J Cell Biol 166: 419-431.
36. Jemal A, Siegel R, Ward E et al (2008). Cancer statistics, 2008. CA Cancer J Clin 58: 71-96.
37. Jiang H, Liu L, Ye J et al (2010). Focal adhesion kinase serves as a marker of cervical lymph node metastasis and is a potential therapeutic target in tongue cancer. J Cancer Res Clin Oncol 136: 1295-1302.
38. Johnson TR, Khandrika L, Kumar B et al (2008). Focal adhesion kinase controls aggressive phenotype of androgen-independent prostate cancer. Mol Cancer Res 6: 1639-1648.
39. Joo NE, Watanabe T, Chen C et al (2008). NG2, a novel proapoptotic receptor, opposes integrin alpha4 to mediate anoikis through PKCalpha-dependent suppression of FAK phosphorylation. Cell Death Differ 15: 899-907.
40. Kamarajan P, Kapila YL (2007). An altered fibronectin matrix induces anoikis of human squamous cell carcinoma cells by suppressing integrin alpha v levels and phosphorylation of FAK and ERK. Apoptosis 12: 2221-2231.
41. Kamarajan P, Bunek J, Lin Y, Nunez G, Kapila YL (2010). Receptor-interacting protein shuttles between cell death and survival signaling pathways. Mol Biol Cell 21: 481-488.
42. Kapila YL, Niu J, Johnson PW (1997). The high affinity heparin-binding domain and the V region of fibronectin mediate invasion of human oral squamous cell carcinoma cells in vitro. J Biol Chem 272: 18932-18938.
43. Kapila YL, Wang S, Johnson PW (1999). Mutations in the heparin binding domain of fibronectin in cooperation with the V region induce decreases in pp125(FAK) levels plus proteoglycan-mediated apoptosis via caspases. J Biol Chem 274: 30906-30913.
44. Khotskaya YB, Dai Y, Ritchie JP et al (2009). Syndecan-1 is required for robust growth, vascularization, and metastasis of myeloma tumors in vivo. J Biol Chem 284: 26085-26095.
45. Kim JW, Choi EJ, Joe CO (2000). Activation of death-inducing signaling complex (DISC) by pro-apoptotic C-terminal fragment of RIP. Oncogene 19: 4491-4499.
46. Koschny R, Ganten TM, Sykora J et al (2007). TRAIL/bortezomib cotreatment is potentially hepatotoxic but induces cancer-specific apoptosis within a therapeutic window. Hepatology 45: 649-658.
47. Kosunen A, Pirinen R, Ropponen K et al (2007). CD44 expression and its relationship with MMP-9, clinicopathological factors and survival in oral squamous cell carcinoma. Oral Oncol 43: 51-59.
48. Kupferman ME, Patel V, Sriuranpong V et al (2007). Molecular analysis of anoikis resistance in oral cavity squamous cell carcinoma. Oral Oncol 43: 440-454.
49. Kurenova E, Xu LH, Yang X et al (2004). Focal adhesion kinase suppresses apoptosis by binding to the death domain of receptor-interacting protein. Mol Cell Biol 24: 4361-4371.
50. Kurihara Y, Hatori M, Ando Y et al (2009). Inhibition of cyclooxygenase-2 suppresses the invasiveness of oral squamous cell carcinoma cell lines via down-regulation of matrix metalloproteinase-2 production and activation. Clin Exp Metastasis 26: 425-432.
51. Laguinge LM, Samara RN, Wang W et al (2008). DR5 receptor mediates anoikis in human colorectal carcinoma cell lines. Cancer Res 68: 909-917.
52. Lange K, Kammerer M, Hegi ME et al (2007). Endothelin receptor type B counteracts tenascin-C-induced endothelin receptor type A-dependent focal adhesion and actin stress fiber disorganization. Cancer Res 67: 6163-6173.
53. LeBlanc HN, Ashkenazi A (2003). Apo2L/TRAIL and its death and decoy receptors. Cell Death Differ 10: 66-75.
54. Lee TH, Huang Q, Oikemus S et al (2003). The death domain kinase RIP1 is essential for tumor necrosis factor alpha signaling to p38 mitogen-activated protein kinase. Mol Cell Biol 23: 8377-8385.
55. Locksley RM, Killeen N, Lenardo MJ (2001). The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 104: 487-501.
56. Loro LL, Vintermyr OK, Johannessen AC, Liavaag PG, Jonsson R (1999). Suppression of Fas receptor and negative correlation of Fas ligand with differentiation and apoptosis in oral squamous cell carcinoma. J Oral Pathol Med 28: 82-87.
57. Lyons AJ, Jones J (2007). Cell adhesion molecules, the extracellular matrix and oral squamous carcinoma. Int J Oral Maxillofac Surg 36: 671-679.
58. Mahmood Z, Shukla Y (2010). Death receptors: targets for cancer therapy. Exp Cell Res 316: 887-899.
59. Masuda T, Wada K, Nakajima A et al (2005). Critical role of peroxisome proliferator-activated receptor gamma on anoikis and invasion of squamous cell carcinoma. Clin Cancer Res 11: 4012-4021.
60. Meylan E, Tschopp J (2005). The RIP kinases: crucial integrators of cellular stress. Trends Biochem Sci 30: 151-159.
61. Misra S, Obeid LM, Hannun YA et al (2008). Hyaluronan constitutively regulates activation of COX-2-mediated cell survival activity in intestinal epithelial and colon carcinoma cells. J Biol Chem 283: 14335-14344.
62. Mitra SK, Hanson DA, Schlaepfer DD (2005). Focal adhesion kinase: in command and control of cell motility. Nat Rev Mol Cell Biol 6: 56-68.
63. Moers C, Warskulat U, Muschen M et al (1999). Regulation of CD95 (Apo-1/Fas) ligand and receptor expression in squamous-cell carcinoma by interferon-gamma and cisplatin. Int J Cancer 80: 564-572.
64. Neiva KG, Zhang Z, Miyazawa M et al (2009). Cross talk initiated by endothelial cells enhances migration and inhibits anoikis of squamous cell carcinoma cells through STAT3/Akt/ERK signaling. Neoplasia 11: 583-593.
65. Noda T, Iwai S, Hamada M, Fujita Y, Yura Y (2009). Induction of apoptosis of detached oral squamous cell carcinoma cells by safingol. Possible role of Bim, focal adhesion kinase and endonuclease G. Apoptosis 14: 287-297.
66. Noutomi T, Itoh M, Toyota H, Takada E, Mizuguchi J (2009). Tumor necrosis factor-related apoptosis-inducing ligand induces apoptotic cell death through c-Jun NH2-terminal kinase activation in squamous cell carcinoma cells. Oncol Rep 22: 1169-1172.
67. Nystrom ML, McCulloch D, Weinreb PH et al (2006). Cyclooxygenase-2 inhibition suppresses alphavbeta6 integrin-dependent oral squamous carcinoma invasion. Cancer Res 66: 10833-10842.
68. Ordonez C, Zhai AB, Camacho-Leal P et al (2007). GPI-anchored CEA family glycoproteins CEA and CEACAM6 mediate their biological effects through enhanced integrin alpha5beta1-fibronectin interaction. J Cell Physiol 210: 757-765.
69. Orian-Rousseau V (2010). CD44, a therapeutic target for metastasising tumours. Eur J Cancer 46: 1271-1277.
70. Orosco A, Fromigue O, Bazille C et al (2007). Syndecan-2 affects the basal and chemotherapy-induced apoptosis in osteosarcoma. Cancer Res 67: 3708-3715.
71. Ozoren N, El-Deiry WS (2003). Cell surface death receptor signaling in normal and cancer cells. Semin Cancer Biol 13: 135-147.
72. Papenfuss K, Cordier SM, Walczak H (2008). Death receptors as targets for anti-cancer therapy. J Cell Mol Med 12: 2566-2585.
73. Ponta H, Sherman L, Herrlich PA (2003). CD44: from adhesion molecules to signalling regulators. Nat Rev Mol Cell Biol 4: 33-45.
74. Roehlecke C, Kuhnt AK, Fehrenbach H et al (2000). Resistance of L132 lung cell clusters to glyoxal-induced apoptosis. Histochem Cell Biol 114: 283-292.
75. Sakamoto S, McCann RO, Dhir R, Kyprianou N (2010). Talin1 promotes tumor invasion and metastasis via focal adhesion signaling and anoikis resistance. Cancer Res 70: 1885-1895.
76. Sato S, Miyauchi M, Kato M et al (2004). Upregulated CD44v9 expression inhibits the invasion of oral squamous cell carcinoma cells. Pathobiology 71: 171-175.
77. Schultze A, Fiedler W (2010). Therapeutic potential and limitations of new FAK inhibitors in the treatment of cancer. Expert Opin Investig Drugs 19: 777-788.
78. Schwock J, Dhani N, Cao MP et al (2009). Targeting focal adhesion kinase with dominant-negative FRNK or Hsp90 inhibitor 17-DMAG suppresses tumor growth and metastasis of SiHa cervical xenografts. Cancer Res 69: 4750-4759.
79. Shanmugathasan M, Jothy S (2000). Apoptosis, anoikis and their relevance to the pathobiology of colon cancer. Pathol Int 50: 273-279.
80. Sharma K, Wang RX, Zhang LY et al (2000). Death the Fas way: regulation and pathophysiology of CD95 and its ligand. Pharmacol Ther 88: 333-347.
81. Shimada Y, Ishii G, Nagai K et al (2009). Expression of podoplanin, CD44, and p63 in squamous cell carcinoma of the lung. Cancer Sci 100: 2054-2059.
82. Shiraki K, Yamanaka T, Inoue H et al (2005). Expression of TNF-related apoptosis-inducing ligand in human hepatocellular carcinoma. Int J Oncol 26: 1273-1281.
83. Simonitsch I, Krupitza G (1998). Autocrine self-elimination of cultured ovarian cancer cells by tumour necrosis factor alpha (TNF-alpha). Br J Cancer 78: 862-870.
84. Stetler-Stevenson WG (1996). Dynamics of matrix turnover during pathologic remodeling of the extracellular matrix. Am J Pathol 148: 1345-1350.
85. Streuli CH, Gilmore AP (1999). Adhesion-mediated signaling in the regulation of mammary epithelial cell survival. J Mammary Gland Biol Neoplasia 4: 183-191.
86. Swan EA, Jasser SA, Holsinger FC et al (2003). Acquisition of anoikis resistance is a critical step in the progression of oral tongue cancer. Oral Oncol 39: 648-655.
87. Tang MKS, Zhou HY, Yam JWP, Wong AST (2010). c-Met overexpression contributes to the acquired apoptotic resistance of nonadherent ovarian cancer cells through a cross talk mediated by phosphatidylinositol 3-kinase and extracellular signal-regulated kinase 1/2. Neoplasia 12: 128-138.
88. Taylor RC, Cullen SP, Martin SJ (2008). Apoptosis: controlled demolition at the cellular level. Nat Rev Mol Cell Biol 9: 231-241.
89. Tkachenko E, Rhodes JM, Simons M (2005). Syndecans: new kids on the signaling block. Circ Res 96: 488-500.
90. To K, Fotovati A, Reipas KM et al (2010). Y-box binding protein-1 induces the expression of CD44 and CD49f leading to enhanced self-renewal, mammosphere growth, and drug resistance. Cancer Res 70: 2840-2851.
91. Valentinis B, Reiss K, Baserga R (1998). Insulin-like growth factor-I-mediated survival from anoikis: role of cell aggregation and focal adhesion kinase. J Cell Physiol 176: 648-657.
92. Wei L, Yang Y, Zhang X, Yu Q (2004). Altered regulation of Src upon cell detachment protects human lung adenocarcinoma cells from anoikis. Oncogene 23: 9052-9061.
93. Wendt MK, Drury LJ, Vongsa RA, Dwinell MB (2008). Constitutive CXCL12 expression induces anoikis in colorectal carcinoma cells. Gastroenterology 135: 508-517.
94. Zhang Y, Lu H, Dazin P, Kapila Y (2004a). Functional differences between integrin alpha4 and integrins alpha5/alphav in modulating the motility of human oral squamous carcinoma cells in response to the V region and heparin-binding domain of fibronectin. Exp Cell Res 295: 48-58.
95. Zhang Y, Lu H, Dazin P, Kapila Y (2004b). Squamous cell carcinoma cell aggregates escape suspension-induced, p53-mediated anoikis: fibronectin and integrin alphav mediate survival signals through focal adhesion kinase. J Biol Chem 279: 48342-48349.
96. Ziober BL, Silverman SS Jr, Kramer RH (2001). Adhesive mechanisms regulating invasion and metastasis in oral cancer. Crit Rev Oral Biol Med 12: 499-510.
97. Zouq NK, Keeble JA, Lindsay J et al (2009). FAK engages multiple pathways to maintain survival of fibroblasts and epithelia: differential roles for paxillin and p130Cas. J Cell Sci 122: 357-367.